Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

Immune‐related radiological and biomarker monitoring in cancer immunotherapy trials permits interrogation of efficacy and reasons for therapeutic failure. We report the results from a cross‐sectional analysis of response monitoring in 685 T‐cell checkpoint‐targeted cancer immunotherapy trials in sol...

Descripción completa

Detalles Bibliográficos
Autores principales: Connell, Claire M., Raby, Sophie E.M., Beh, Ian, Flint, Thomas R., Williams, Edward H., Fearon, Douglas T., Jodrell, Duncan I., Janowitz, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759814/
https://www.ncbi.nlm.nih.gov/pubmed/29021379
http://dx.doi.org/10.1634/theoncologist.2017-0226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759814/
https://www.ncbi.nlm.nih.gov/pubmed/29021379
http://dx.doi.org/10.1634/theoncologist.2017-0226

Ejemplares similares